Northwire Canada EditionMonday, July 13, 2026
Northwire
BMM 3.80 +0.0% CGD 0.510 −10.5% OCG 0.275 −1.8% CAMB 0.990 −1.0% HMR 0.610 −1.6% GOFL 0.025 +0.0% SIG 1.02 −1.0% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.405 +1.2% LIB 0.805 −11.5% SMY 0.290 +23.4% SAG 1.02 +0.0% NTH 0.165 +0.0% BMM 3.80 +0.0% CGD 0.510 −10.5% OCG 0.275 −1.8% CAMB 0.990 −1.0% HMR 0.610 −1.6% GOFL 0.025 +0.0% SIG 1.02 −1.0% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.405 +1.2% LIB 0.805 −11.5% SMY 0.290 +23.4% SAG 1.02 +0.0% NTH 0.165 +0.0%
Regulatory

Trulieve gains conditional approval for Texas licence

TRUL · Price

Executive Summary

  • Trulieve Cannabis Corp. (via its subsidiary Trulieve TX Inc.) has received conditional approval from the Texas Department of Public Safety for a dispensing organization license under the Texas Compassionate Use Program.
  • This approval allows Trulieve to cultivate, manufacture, and distribute high-quality medical cannabis products to patients in Texas, pending final regulatory sign-off.
  • The company views this as a significant expansion into a new market, aiming to provide compassionate care and expanded access to medical cannabis in the state.

Key Details

  • Regulatory Body: Texas Department of Public Safety.
  • License Type: Conditional approval for a dispensing organization license under the Texas Compassionate Use Program.
  • Approved Entity: Trulieve TX Inc. (subsidiary of Trulieve Cannabis Corp.).
  • Scope of Operations: The license permits Trulieve to cultivate, manufacture, and distribute medical cannabis products to Texas patients.
  • Status: The license is currently conditional and remains subject to final approval by the Texas Department of Public Safety.
  • Strategic Context: Trulieve is a vertically integrated, multistate cannabis operator with existing market positions in Arizona, Florida, and Pennsylvania, utilizing a "hub strategy" for expansion.

Notable Quotes

  • "We are excited to be selected for a coveted Texas dispensing organization licence and we look forward to working with regulators as we complete the licensing process," said Kim Rivers, chief executive officer of Trulieve.
  • "Pending necessary approvals, we plan to provide patients compassionate care and expanded access to high-quality medical cannabis products."
Read the original news release →

More from Trulieve Cannabis Corp